4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings
Weiss Ratings reiterated their sell (e+) rating on shares of 4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) in a ...
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have been assigned a consensus recommendation of ...